Detalles de la búsqueda
1.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126318
2.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
3.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335916
4.
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Ann Hematol
; 102(5): 1099-1109, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959485
5.
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
Mycoses
; 66(1): 35-46, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36064299
6.
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey.
Mycoses
; 65(2): 171-177, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695256
7.
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study.
Br J Haematol
; 193(2): 316-324, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33058237
8.
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.
Haematologica
; 106(1): 39-45, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879328
9.
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group.
Am J Hematol
; 94(10): 1104-1112, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321791
10.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771466
11.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388854
12.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.
Am J Hematol
; 98(4): E80-E83, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651870
13.
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Haematologica
; 107(4): 996-999, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021604
14.
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Int J Antimicrob Agents
; 61(6): 106806, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37030470
15.
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
Cancers (Basel)
; 15(18)2023 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760592
16.
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.
Cancers (Basel)
; 15(13)2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444567
17.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol
; 16(1): 32, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005697
18.
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.
EClinicalMedicine
; 58: 101939, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041967
19.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents
; 62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478
20.
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study.
J Fungi (Basel)
; 8(6)2022 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736066